Approval of Drugs With Unmet Trial End Points-In Reply.
| Autor: | Johnston JL; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Ross JS; Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Ramachandran R; Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | JAMA internal medicine [JAMA Intern Med] 2023 Aug 01; Vol. 183 (8), pp. 889-890. |
| DOI: | 10.1001/jamainternmed.2023.2240 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|